Editas Medicine, Inc. (0IFK.L)
USD 1.46
(-4.63%)
USD 1.46
(-4.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -132.17 Million | -177.34 Million | -163.8 Million | -179.84 Million | -40.66 Million | -45.7 Million |
| Net Income | -153.21 Million | -220.43 Million | -192.5 Million | -115.97 Million | -133.74 Million | -109.95 Million |
| Depreciation & Amortization | 6.06 Million | 6.33 Million | 5.05 Million | 3.95 Million | 2.83 Million | 3.25 Million |
| Deferred income taxes | 6.53 Million | - | - | -16.36 Million | - | -3.66 Million |
| Stock-based compensation | 19.79 Million | 29.29 Million | 43.39 Million | 23.15 Million | 27.24 Million | 26.59 Million |
| Change in working capital | -1.59 Million | 8.17 Million | -21.41 Million | -102.22 Million | 65.93 Million | 26.88 Million |
| Other non-cash items | -9.76 Million | -724 Thousand | 1.65 Million | 27.6 Million | -2.92 Million | 11.17 Million |
| Investing Cash Flow | -3.73 Million | 114.06 Million | -54.46 Million | -140.52 Million | 12.25 Million | -53.08 Million |
| Investments in PPE | -4.71 Million | -4.11 Million | -7.97 Million | -7.16 Million | -6.16 Million | -4.75 Million |
| Acquisitions | -988 Thousand | 18 Thousand | 46.48 Million | 12 Thousand | 102 Thousand | 37 Thousand |
| Investment purchases | -258.51 Million | -315.18 Million | -408.89 Million | -458.4 Million | -342.18 Million | -459.37 Million |
| Sales/Maturities of investments | 259.5 Million | 433.35 Million | 362.4 Million | 325.03 Million | 360.5 Million | 411 Million |
| Other Investing Activities | 988 Thousand | 118.18 Million | -46.48 Million | -133.36 Million | 18.41 Million | 37 Thousand |
| Financing Cash Flow | 118.03 Million | 1.28 Million | 282.1 Million | 224.12 Million | 131.82 Million | 86.94 Million |
| Debt repayment | - | - | - | - | - | -857 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 4000.00 |
| Common Stock Issuance | 118.03 Million | 979 Thousand | 282.1 Million | 224.12 Million | 116.34 Million | 87.79 Million |
| Other Financing Activities | 960 Thousand | 305 Thousand | 282.1 Million | 224.12 Million | 15.48 Million | 87.79 Million |
| Accounts receivables | -5.04 Million | -4.87 Million | 5.78 Million | -5.63 Million | -388 Thousand | 649 Thousand |
| Accounts payables | -1.49 Million | 4.36 Million | -1.13 Million | 855 Thousand | 274 Thousand | 1.78 Million |
| Inventory | - | - | -3.34 Million | -5.65 Million | 10.65 Million | 1.57 Million |
| Other working capital | 4.94 Million | 8.68 Million | -22.7 Million | -91.79 Million | 55.39 Million | 22.88 Million |
| Cash at beginning of period | 141.52 Million | 207.39 Million | 143.55 Million | 239.8 Million | 136.39 Million | 148.24 Million |
| Cash at end of period | 123.65 Million | 145.39 Million | 207.39 Million | 143.55 Million | 239.8 Million | 136.39 Million |
| Capital Expenditure | -4.71 Million | -4.11 Million | -7.97 Million | -7.16 Million | -6.16 Million | -4.75 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -17.87 Million | -61.99 Million | 63.83 Million | -96.24 Million | 103.4 Million | -11.85 Million |
| Free Cash Flow | -136.89 Million | -181.46 Million | -171.78 Million | -187 Million | -46.83 Million | -50.46 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -62.14 Million | -67.6 Million | -61.95 Million | -153.21 Million | -18.87 Million | -45.01 Million |
| Depreciation & Amortization | -3.32 Million | 1.42 Million | 1.4 Million | 6.06 Million | 1.46 Million | 1.51 Million |
| Deferred income taxes | - | - | - | 6.53 Million | -18.63 Million | 1.79 Million |
| Stock-based compensation | 4.8 Million | 5.01 Million | 7.58 Million | 19.79 Million | 5.34 Million | 4.73 Million |
| Change in working capital | -11.21 Million | 6.41 Million | 4.8 Million | -1.59 Million | -8.08 Million | 4.56 Million |
| Other non-cash items | 19.28 Million | -1.86 Million | 201 Thousand | -9.76 Million | 16.54 Million | -3.04 Million |
| Investing Cash Flow | 83.97 Million | 51.95 Million | -4.74 Million | -3.73 Million | 62.84 Million | -102.82 Million |
| Investments in PPE | -2.92 Million | -3.49 Million | -1.87 Million | -4.71 Million | -1.3 Million | -239 Thousand |
| Acquisitions | - | - | - | -988 Thousand | -64.14 Million | 102.58 Million |
| Investment purchases | - | 3000.00 | -86.22 Million | -258.51 Million | -38.75 Million | -151.58 Million |
| Sales/Maturities of investments | 86.9 Million | 55.44 Million | 83.35 Million | 259.5 Million | 102.9 Million | 49 Million |
| Other Investing Activities | - | 55.44 Million | -2.87 Million | 988 Thousand | 64.14 Million | -102.58 Million |
| Financing Cash Flow | - | 322 Thousand | 192 Thousand | 118.03 Million | 514 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 322 Thousand | - | - | - | - | - |
| Common Stock Issuance | -514 Thousand | 322 Thousand | 192 Thousand | 118.03 Million | 514 Thousand | - |
| Other Financing Activities | -322 Thousand | 322 Thousand | 192 Thousand | 960 Thousand | 514 Thousand | - |
| Accounts receivables | 118 Thousand | 1000.00 | 9.94 Million | -5.04 Million | -7.76 Million | -136 Thousand |
| Accounts payables | -1.25 Million | 7.42 Million | -1.45 Million | -1.49 Million | -2.59 Million | 2.35 Million |
| Inventory | - | - | - | - | 1.00 | - |
| Other working capital | 4.7 Million | -1.01 Million | -3.68 Million | 4.94 Million | 2.27 Million | 2.34 Million |
| Cash at beginning of period | 64.44 Million | 69.22 Million | 123.65 Million | 141.52 Million | 82.53 Million | 224.69 Million |
| Cash at end of period | 99.7 Million | 64.44 Million | 69.22 Million | 123.65 Million | 123.65 Million | 86.41 Million |
| Capital Expenditure | -2.92 Million | -3.49 Million | -1.87 Million | -4.71 Million | -1.3 Million | -239 Thousand |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
| Net cash flow / Change in cash | 35.26 Million | -4.78 Million | -54.42 Million | -17.87 Million | 41.11 Million | -138.27 Million |
| Free Cash Flow | -55.5 Million | -60.55 Million | -51.74 Million | -136.89 Million | -23.54 Million | -35.69 Million |
PUBC
OAK
NBBK
KEQU
OSBK
2726